Explore
Validate
Learn
Immunocytochemistry
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA063793 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA063793, RRID:AB_2685123
- Product name
- Anti-MARCO
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human MARCO, Gene description: macrophage receptor with collagenous structure, Alternative Gene Names: SCARA2, Validated applications: IHC, ICC, Uniprot ID: Q9UEW3, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.3 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references An In Vivo Model of Human Macrophages in Metastatic Melanoma
High Infiltration of CD68+/CD163- Macrophages Is an Adverse Prognostic Factor after Neoadjuvant Chemotherapy in Esophageal and Gastric Adenocarcinoma.
Multi-omics characterization reveals the pathogenesis of liver focal nodular hyperplasia.
A Single-Cell Transcriptional Roadmap of the Mouse and Human Lymph Node Lymphatic Vasculature
Tumor-Associated CD68(+), CD163(+), and MARCO(+) Macrophages as Prognostic Biomarkers in Patients With Treatment-Naïve Gastroesophageal Adenocarcinoma.
The clinical importance of tumour-infiltrating macrophages and dendritic cells in periampullary adenocarcinoma differs by morphological subtype.
Voillet V, Berger T, McKenna K, Paulson K, Tan W, Smythe K, Hunter D, Valente W, Weaver S, Campbell J, Kim T, Byrd D, Bielas J, Pierce R, Chapuis A, Gottardo R, Rongvaux A
The Journal of Immunology 2022;209(3):606-620
The Journal of Immunology 2022;209(3):606-620
High Infiltration of CD68+/CD163- Macrophages Is an Adverse Prognostic Factor after Neoadjuvant Chemotherapy in Esophageal and Gastric Adenocarcinoma.
Svensson MC, Svensson M, Nodin B, Borg D, Hedner C, Hjalmarsson C, Leandersson K, Jirström K
Journal of innate immunity 2022;14(6):615-628
Journal of innate immunity 2022;14(6):615-628
Multi-omics characterization reveals the pathogenesis of liver focal nodular hyperplasia.
Liu Y, Zhang J, Wang Z, Ma J, Wang K, Rao D, Zhang M, Lin Y, Wu Y, Yang Z, Dong L, Ding Z, Zhang X, Fan J, Shi Y, Gao Q
iScience 2022 Sep 16;25(9):104921
iScience 2022 Sep 16;25(9):104921
A Single-Cell Transcriptional Roadmap of the Mouse and Human Lymph Node Lymphatic Vasculature
Xiang M, Grosso R, Takeda A, Pan J, Bekkhus T, Brulois K, Dermadi D, Nordling S, Vanlandewijck M, Jalkanen S, Ulvmar M, Butcher E
Frontiers in Cardiovascular Medicine 2020;7
Frontiers in Cardiovascular Medicine 2020;7
Tumor-Associated CD68(+), CD163(+), and MARCO(+) Macrophages as Prognostic Biomarkers in Patients With Treatment-Naïve Gastroesophageal Adenocarcinoma.
Jeremiasen M, Borg D, Hedner C, Svensson M, Nodin B, Leandersson K, Johansson J, Jirström K
Frontiers in oncology 2020;10:534761
Frontiers in oncology 2020;10:534761
The clinical importance of tumour-infiltrating macrophages and dendritic cells in periampullary adenocarcinoma differs by morphological subtype.
Lundgren S, Karnevi E, Elebro J, Nodin B, Karlsson MCI, Eberhard J, Leandersson K, Jirström K
Journal of translational medicine 2017 Jul 3;15(1):152
Journal of translational medicine 2017 Jul 3;15(1):152
No comments: Submit comment
Supportive validation
- Submitted by
- Atlas Antibodies (provider)
- Enhanced method
- Orthogonal validation
- Main image
- Experimental details
- Immunohistochemistry analysis in human lung and pancreas tissues using HPA063793 antibody. Corresponding MARCO RNA-seq data are presented for the same tissues.
- Sample type
- Human
- Protocol
- Protocol
